Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-04

Clinical Trial Update: Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes

View source ↗

Summary

This document provides a clinical trial update on a fixed-dose combination tablet of metformin hydrochloride and empagliflozin for type 2 diabetes, with the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)
  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Type 2 Diabetes | Status: ACTIVE_NOT_RECRUITING